Search Results - "Amani‐Bosse, C"

Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109) by Hirt, D, Urien, S, Ekouévi, DK, Rey, E, Arrivé, E, Blanche, S, Amani‐Bosse, C, Nerrienet, E, Gray, G, Kone, M, Leang, SK, McIntyre, J, Dabis, F, Tréluyer, J‐M

“…Thirty‐eight human immunodeficiency virus‐1 (HIV‐1)‐infected pregnant women were administered tenofovir disoproxil fumarate (TDF; 300 mg)–emtricitabine (FTC;…”
Get full text

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa : evaluation of two-tiered approach by TONWE-GOLD, B, EKOUEVI, D.K, ABRAMS, E.J, DABIS, F, VIHO, I, AMANI-BOSSE, C, TOURE, S, COFFIE, P.A, ROUET, F, BECQUET, R, LEROY, V, EL-SADR, W

“…Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in…”
Get full text

Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission by Dabis, François, Bequet, Laurence, Ekouevi, Didier Koumavi, Viho, Ida, Rouet, François, Horo, Apollinaire, Sakarovitch, Charlotte, Becquet, Renaud, Fassinou, Patricia, Dequae-Merchadou, Laurence, Welffens-Ekra, Christiane, Rouzioux, Chrisitine, Leroy, Valériane

“…In Africa, single-dose nevirapine (NVPsd), short regimens of zidovudine (ZDV) or ZDV + lamivudine (3TC) are recommended to prevent peripartum mother-to-child…”
Get full text

Population Pharmacokinetics ofTenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109) by HIRT, D, URIEN, S, LEANG, S. K, MCINTYRE, J, DABIS, F, TRELUYER, J-M, EKOUEVI, D. K, REY, E, ARRIVE, E, BLANCHE, S, AMANI-BOSSE, C, NERRIENET, E, GRAY, G, KONE, M

Get full text

CD4 Percentages and Total Lymphocyte Counts as Early Surrogate Markers for Pediatric HIV-1 Infection in Resource-Limited Settings by Rouet, François, Inwoley, André, Ekouevi, Didier K., Viho, Ida, Becquet, Renaud, Sakarovitch, Charlotte, Bequet, Laurence, Tonwe-Gold, Besigin, Chaix, Marie-Laure, Leroy, Valériane, Rouzioux, Christine, Dabis, François

“…The early diagnosis of pediatric HIV-1 infection is a critical issue in resource-limited settings to prioritize eligibility for antiretroviral therapy among…”
Get full text

SFCP P-096 - Accès au traitement antirétroviral avant deux ans à Abidjan by Timite-Konan, M., Avit-Edi, D., Méa-Assandé, V., Aka, E., Kouadio, S., Folquet-Amorissani, M., Amani-Bossé, C., Eliam-Kouakou, J., Daingui, E., Abo, K., Ahoba, I., Leroy, V.

“…Etudier l’accès au traitement antirétroviral précoce (TAP) chez les enfants infectés par le VIH de moins de deux ans à Abidjan. Lors du recrutement dans…”
Get full text

SFP PC-83 – Inclusion dans un essai du traitement antirétroviral pédiatrique en Afrique by Eboua, T.K.F., Yonaba, C., Mea-Assande, V., Ouedraogo, S., Amani-Bossé, C., Coulibaly, M., Meda, N., Timité-Konan, M., Yé, D., Amorissani-Folquet, M., Lepage, P., Leroy, V., Blanche, S.

“…Décrire l’inclusion dans un essai de simplification du traitement antirétroviral (TAR) avant l’âge de deux ans. L’essai MONOD-ANRS-12206 est un essai contrôlé…”
Get full text